TABLE 1.
Analysis 1 | Analysis 2 | Analysis 3 | Analysis 4 | |
---|---|---|---|---|
Pollen sensitizations (n = 2948) | CCDs & panallergens (n = 600) | molecular sensitivity (n = 636)> | Molecular specificity (n = 106) | |
Sex | ||||
Females | 52.9% | 50.2% | 56.3% | 67.9% |
Age [years] | ||||
Median | 29 | 28 | 32 | 36 |
Interquartile ranges | 17‐43 | 16‐41 | 20‐43 | 25‐54 |
Frequency of symptoms | ||||
Rhinitis | 79.5% | 84.5% | 93.7% | 61.3% |
Conjunctivitis | 32.1% | 50.0% | 63.8% | 26.4% |
Bronchitis | 20.1% | 15.5% | 16.8% | 23.6% |
Asthma | 8.8% | 8.8% | 5.2% | 7.5% |